Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-05

Clinical Trial Update: Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing, Immunotherapy or Oral Challenges [Phase 1]

View source ↗

Summary

Phase 1 trial studying whether inhaled epinephrine can lessen systemic allergic reactions during allergy testing, immunotherapy, or oral challenges; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inhaled epinephrine (epinephrine)

Snippet

Sponsor: Dr. George Luciuk | Conditions: Hypersensitivity, Anaphylaxis | Phase 1 | Status: RECRUITING